(Cys(Acm)20·31)-EGF (20-31) is a truncated epidermal growth factor (EGF) fragment with cysteine substitutions at positions 20 and 31, facilitating disulfide bond formation and enhancing peptide stability. The Acm protection group helps stabilize the cysteine residues. Researchers use it in studies of EGF receptor interactions, cell proliferation, and wound healing mechanisms, focusing on receptor-binding dynamics.
3. Emu oil in combination with other active ingredients for treating skin imperfections
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More